: Kamal N. Tiwari
- Kamal N. Tiwari first started conducting FDA inspections in 2024, with the last inspection in 2024. Over that time, Kamal N. Tiwari has conducted 2 inspections at 1 companies across 2 sites.
Get Kamal Tiwari's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 KBI Biopharma, Inc., Durham | 2024
Out-of-stock
Kamal N. Tiwari
Human Drugs Form 483